Cargando…
Development of [(18)F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis
Insufficient apoptosis is a recognised hallmark of cancer. A strategy to quantitatively measure apoptosis in vivo would be of immense value in both drug discovery and routine patient management. The first irreversible step in the apoptosis cascade is activation of the “executioner” caspase-3 enzyme...
Autores principales: | García-Argüello, Segundo Francisco, Lopez-Lorenzo, Beatriz, Cornelissen, Bart, Smith, Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465189/ https://www.ncbi.nlm.nih.gov/pubmed/32781531 http://dx.doi.org/10.3390/cancers12082191 |
Ejemplares similares
-
Clinical translation of [(18)F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
por: Dubash, S. R., et al.
Publicado: (2018) -
Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using (18)F-ICMT-11 and (18)F-FLT PET
por: Heinzmann, Kathrin, et al.
Publicado: (2018) -
Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2014) -
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
Publicado: (2014) -
Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2020)